Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
Trial details
- Registry ID
- NCT05942911
- Phase
- Phase 2
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as HCQ; Plaquenil
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid ArthritisNCT05942911 | Incannex Healthcare Ltd | Phase 2 | Terminated | 2024-10-28Actual |
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |